Navigation Links
Over 2,500 Cases Now Filed in Federal Actos Lawsuit Litigation; Case Management Conference Scheduled to Take Place on Thursday
Date:10/23/2013

New York, NY (PRWEB) October 23, 2013

More than 2,500 Actos lawsuit (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) claims alleging bladder cancer are now pending in a federal multidistrict litigation established in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.

According to a case list update issued October 17th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), the number of lawsuits filed in the proceeding has reached 2,587. Plaintiffs involved in these cases similarly allege that long-term use of the diabetes medication, manufactured by Takeda Pharmaceuticals, can cause bladder cancer. The next Case Management Conference in the federal Actos lawsuit litigation is scheduled to take place on Thursday, October 24th 2013 at 10:30 a.m. (In re: Actos Product Liability Litigation, MDL No. 2299)

“We are not at all surprised to see the number of Actos lawsuits grow in the federal proceeding, as our Firm regularly hears from diabetics who were diagnosed with bladder cancer after long-term use of the medication,” says Bernstein Liebhard LLP, a nationwide law firm representing individuals harmed by defective drugs and medical devices. Call the Firm’s toll-free number today to receive a free and confidential case evaluation of your potential Actos lawsuit.

Actos Lawsuits
Actos lawsuits currently pending in the Western District of Louisiana were filed after a June 2011 alert from the U.S. Food and Drug Administration (FDA) warned about the drug’s association with bladder cancer. Specifically, Takeda Pharmaceuticals was ordered at that time to adjust its Actos labeling to include its potential to cause bladder cancer in diabetics who took the medication for 12 months or more.

Court records indicate that the federal Actos proceeding’s first trial is scheduled to begin in January. This is the first of more than 2,500 cases to head to trial over the diabetes drug, after being brought by plaintiffs who similarly allege that Takeda failed to adequately warn diabetics about the potential for its product to cause bladder cancer prior to the FDA warning in June 2011.

Before then, the company concealed knowledge of this risk, according to lawsuits.
Although federal Actos trials are just beginning, two cases involving the diabetes drug have already gone to trial at the state court level. In September 2013, the family of a man who died of bladder cancer after taking Actos for a long period of time was awarded $1.7 million by a jury in Maryland State Court. Soon after the verdict was reached, however, it was tossed by the judge who found that the patient had smoked for several decades prior to his death, which may have partially contributed to his bladder cancer. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland)

A decision to rule in favor of the plaintiff in a state court-filed Actos lawsuit was set aside earlier this year in Los Angeles Superior Court after a jury awarded $6.5 to an individual who was diagnosed with bladder cancer after taking Actos for four years. This verdict was then set aside by the judge overseeing the case; a decision the plaintiff is now appealing. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)

Individuals who took the diabetes drug, Actos, and were diagnosed with bladder cancer after long-term use of the medication may be entitled to compensation for damages related to their alleged suffering. Learn more about the process of filing an Actos lawsuit against Takeda Pharmaceuticals by visiting Bernstein Liebhard LLP’s website. You may also contact the firm directly at 800-511-5092 today.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/Actos-lawsuit/Actos-lawyer/prweb11262571.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. California Facial Plastic Surgeon Recently Reported Performing Over 2,500 Facelifts Using His Innovative Technique
2. Actos Bladder Cancer Lawsuits Help: Resource4thePeople Reports Number of Consolidated Federal Cases Climbs to over 2,500
3. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
4. Pneumococcal disease: More cases but fewer deaths
5. Asthma Cases Continue to Rise in U.S., Affecting Millions
6. As Obesity Rates Rise, Cases of Kidney Stones Double: Study
7. Community-acquired MRSA cases on the rise in New York City, study suggests
8. New treatment protocol extends survival in some cases of once inoperable pancreatic cancer
9. Hospitals in recession-hit areas see uptick in serious cases of child physical abuse
10. Whooping Cough Cases Reaching Record Highs: CDC
11. 1 in 20 Cases of Melanoma Linked to Tanning Beds: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the ... narrowly passed the U.S. House on May 4, would result in 23 million Americans ... continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). , ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a ... announce a new, informational blog post on insurance options. If a Bay Area patient ... may help save time and money. Visiting an in-network provider for a second opinion ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “Cactus Jack: Against ... on so many others. “Cactus Jack: Against All Odds” is the creation of ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter ...
(Date:5/24/2017)... Hills, CA (PRWEB) , ... May 24, 2017 , ... ... announced today its participation in nVerge 2017 – a one-day technology conference in San ... Altec’s document management solution, which allows users to fully utilize and enhance their Sage ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/6/2017)... , May 5, 2017  May is Stroke ... one of the most important methods to prevent a ... the Centers for Disease Control and Prevention, undetected and ... 1 Omron, the global leader in personal heart ... the elimination of heart attack and stroke and is ...
Breaking Medicine Technology: